SCHEMBL22520127

SCHEMBL22520127

COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(O)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30381642 0.93 EGFR (1.00) EGFR
SCHEMBL22025688 0.93 EGFR (1.00) EGFR
SCHEMBL22025654 0.92 EGFR (0.86) EGFR
SCHEMBL22520134 0.92 EGFR (0.86) EGFR
SCHEMBL22025685 0.91 EGFR (0.85) EGFR
SCHEMBL22025903 0.91 EGFR (1.00) EGFR
SCHEMBL22595133 0.91 EGFR (0.85) EGFR
SCHEMBL22025684 0.91 EGFR (0.84) EGFR
SCHEMBL22821783 0.90 EGFR (0.83) EGFR
SCHEMBL22821733 0.90 EGFR (0.95) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 — — WO disclosed
Send feedback